{"nct_id":"NCT02684370","title":"BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis","status":"COMPLETED","status_verified_date":"2021-07","start_date":"2016-02","start_date_type":"ACTUAL","primary_completion_date":"2016-12","primary_completion_date_type":"ACTUAL","completion_date":"2017-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}